USCWA
BMRN icon

U.S. Capital Wealth Advisors’s BioMarin Pharmaceuticals BMRN Stock Holding History

U.S. Capital Wealth Advisors’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-153
Closed -$15.8K – 752
2022
Q4 		$15.8K Buy
+153
New +$15.8K ﹤0.01% 1158